Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Medical Education
  • Medical Admission News
  • AIIMS Revises...

AIIMS Revises Institute Allocation Schedule for DM, MCh, MD(HA) Admissions, January 2025 Session

Divyani PaulWritten by Divyani Paul Published On 2024-12-27T12:15:16+05:30  |  Updated On 27 Dec 2024 12:15 PM IST
AIIMS Revises Institute Allocation Schedule for DM, MCh, MD(HA) Admissions, January 2025 Session.
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi- All India Institute of Medical Sciences (AIIMS) has revised the online institute Allocation for admission to DM/M.Ch/MD(HA) courses of INIss for the January 2025 session. The revised schedule has also been released for the candidates participating in the allocation on the AIIMS official website.

As per the revised schedule, the online institute allotment for admission to DM/M.Ch/MD(HA) courses of INISS for the January 2025 session has now been started on 26 December 2024 and will end on 09 February 2024. In which, the 1st Round of Online Institute Allocation started on 26 December 2024 and will end on 06th January 2024, the 2nd Round of Online Institute Allocation will start on 16th January 2024 and will end on 23rd January 2024 and the 3rd Round of Online Institute Allocation will start on 04th January 2024 and will end on 09 February 2024.

Also Read: AIIMS INI SS January 2025 choice filling till December 22, check complete schedule, all admission details here

The revised schedule of online Institute allocation will be opened for admission to DM/M.Ch/MD(HA) courses of INIs for the January 2025 session as per the details given below-

SCHEDULE FOR 1ST ROUND OF ONLINE INSTITUTE ALLOCATION

S.NO

PARTICULARS

DATE & TIME

1

Exercising of Choices (Institute against applied subject/speciality) for the First Round.

26 December 2024,(Thursday) to 29 December 2024 up to 05.00 pm (Sunday)

2

Announcement of Institute allocation of 1st Round.

31 December 2024 (Tuesday)

3

Online Acceptance of allocated Institute.

01 January 2025, 11.00 am (Wednesday) to 06 January 2025 up to 05.00 pm (Monday)

4

Reporting & Submission of Documents/Security Deposit.

01 January 2025, 11.00 am (Wednesday) to 06 January 2025 up to 05.00 pm (Monday)

SCHEDULE FOR 2ND ROUND OF ONLINE INSTITUTE ALLOCATION

S.NO

PARTICULARS

DATE & TIME

1

Announcement of Institute allocation of 2nd Round.

16 January 2025 (Thursday)

2

Online Acceptance of allocated Institute.

17 January 2025, 11.00 am (Friday) to 23 January 2025 up to 05.00 pm (Thursday)

3

Reporting & Submission of Documents/Security Deposit.

17 January 2025, 11.00 am (Friday) to 23 January 2025 up to 05.00 pm (Thursday)

SCHEDULE FOR 3RD ROUND OF ONLINE INSTITUTE ALLOCATION

S.NO

PARTICULARS

DATE & TIME

1

Announcement of Institute allocation of 3rd Round.

04 February 2025 (Tuesday)

2

Online Acceptance of allocated Institute.

05 February 2025, 11.00 am (Wednesday) to 09 February 2025 up to 05.00 pm (Sunday)

3

Reporting & Submission of Documents/Security Deposit.

05 February 2025, 11.00 am (Wednesday) to 09 February 2025 up to 05.00 pm (Sunday)

Meanwhile, as per the information brochure for the 1st round of online Insitute Allocation (Institute against applied subject/speciality)/ process for DM/MCh/MD(HA) courses for the January 2025 session, Candidates as per both results will be eligible to participate in the 1st Round of the Online Institute Allocation.

PROCEDURE

1 The eligible candidates will have to register themselves on the INI-SS Online Institute Allocation portal. The link for the portal will be activated only for eligible candidates on the My Page. Candidates can log in using the credentials that have been used for filling application form and completing other processes related to the INI-SS Entrance Examination for the January 2025 session.

2 The INI-SS Online Institute Allocation portal will allow candidates to make choices of Institute (a combination of Institute against applied subject/speciality) as per his/her eligibility. The candidate can arrange the choices in the desired order preference. There is no limitation on the number of choices (Institutes) that can be made by the candidates subject to eligibility. The choices can be edited and reordered within the date and time specified in the Important Dates link in the Portal.

3 The Portal will remain open on dates specified in the Important Dates link in the Portal. The choices made by the candidate will be locked either by the candidate OR will be automatically locked on the last Date and Time as specified in the Important Dates link in the Portal.

4 All the candidates who have been allocated Institutes in the 1st Round are required to login into the INI-SS Online Institute Allocation portal and actively choose one of the following options within the date and time specified in the Important Dates link-

Option 1. Accept allotted Institute and do not wish to participate in further rounds of Institute Allocation.

Option 2. Accept allotted Institute and want to participate in 2nd ROUND of Institute Allocation

5 All the candidates who are allocated Institute are mandatorily required to report in person (for reporting and/or joining, to the allocated Institute within the date and times specified in the Important Dates link. The candidates are required to deposit original certificates or a security deposit of Rs. 3.00 Lakh on notification of the Institute allocation of the 1st Round at the time of reporting.

FOREIGN NATIONAL CANDIDATES

a The Institute allocation will be done in order of merit and according to choices made by the candidates as described in point no 2.

b The candidates will be eligible to exercise of choices of Institute only as per applied Subject those are filled in the online registration form and eligibility as per information provided therein.

SPONSORED CANDIDATES

1 The Institute allocation will be done in order of merit and according to choices made by the candidates as described in point no 2 against seats as published in respective categories as per applicable rule.

2 In case any discrepancy is found in online data with the Sponsorship certificate valid information as in the Sponsorship certificate will be accepted as per eligibility criteria.

3 The candidates are eligible to exercise of choice of Institute only as per the applied Subject in which sponsored Institutes are available and issued by the respective competent authority received at the Examination Section AIIMS, New Delhi within specified dates.

4 In case, the NOC has been received in place of the Sponsorship certificate, the Institute allocation will be done as per the subject/Institute available in the online registration.

5 If the subject is not mentioned against the candidate’s name in the Sponsorship certificate, no allocation will be done for that institute.

6 All allocation of Sponsored candidates will be done on the basis of the Institute available against the applied subject and that is mentioned in the Sponsorship Certificate/online registration for the January 2025 session.

7 Only one best Institute available at that rank will be allocated during online Institute allocation.

UPPER AGE LIMIT

1 AIIMS New Delhi & other AIIMS (As on 1st January 2025): The age validation for Courses of AIIMS New Delhi & other AIIMS under INI-SS for the January 2025 session-

General Category- 35 Years (Candidates Born on or after 01.01.1990 are eligible).

‘Sponsored Category’- There is no age limit for Sponsored Category.


2 NIMHANS, Bangalore (As on 1 st January 2025): The age validation for Courses of NIMHANS under INI-SS for the January 2025 session-

General Category- 37 Years (Candidates Born on or after 01.01.1988 are eligible).

‘Sponsored Category’- There is no age limit for Sponsored Category.


3 SCTIMST Trivandrum (As on 1 st January 2025): The age validation for Courses of SCTIMST under INI-SS for the January 2025 session-

General - 40 Years (candidates Born on or after 01.01.1985 are eligible).

Sponsored –There is no age limit for Sponsored Category.


4 PGIMER, Chandigarh (As on 1 st January 2025): The age validation for Courses of PGIMER under INI-SS for the January 2025 session-

General Category- 45 Years (Candidates Born on or after 01.01.1980 are eligible).

‘Sponsored Category’- There is no age limit for Sponsored Category.


5 JIPMER, Puducherry (As on 1 st January 2025): There is no age limit for any category.

To view the revised schedule, click the link below

https://medicaldialogues.in/pdf_upload/aiims-revises-institute-allocation-schedule-for-dm-mch-mdha-admissions-january-2025-session-266684.pdf

To view the information bulletin, click the link below

https://medicaldialogues.in/pdf_upload/information-bulletin-266693.pdf

AIIMSDMMChMD HAINIss
Divyani Paul
Divyani Paul

    I am a student of Journalism and Mass Communication and also a passionate writer and explorer. With a keen interest in medicine, I have joined Medical Dialogues as a Content Writer. Within this role, I curate various healthcare-related news including the latest updates on health, hospitals, and regulatory updates from NMC/DCI. For any query or information, feel free to reach out to me at editorial@medicaldialogues.in

    Show Full Article
    Next Story

    Editorial

    Aspirin Use in Male Smokers Aged 40-45 Years with Hypertension: Identifying the Ideal Candidates

    Aspirin Use in Male Smokers Aged 40-45 Years with Hypertension: Identifying the Ideal Candidates

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    View All

    Journal Club Today

    Global Omega-3 Shortage Poses Serious Health and Environmental Risks: Study

    Global Omega-3 Shortage Poses Serious Health and Environmental Risks: Study

    View All

    Health News Today

    Health Bulletin 31/May/2025

    Health Bulletin 31/May/2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok